A University of Cambridge test involves the use of a VR headset while navigating a simulated environment to help detect Alzheimer’s. Credit: University of Cambridge.

Researchers at the University of Cambridge in the UK have found that virtual reality (VR) could detect early Alzheimer’s disease more accurately compared to existing ‘gold standard’ cognitive tests.

Existing pen-and-paper cognitive tests are not designed to evaluate patients for navigation difficulties, which occur because of damage to the entorhinal cortex region of the brain.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

To address this, a team from the university’s department of clinical neurosciences worked with Professor Neil Burgess at University College London (UCL) to create and assess a VR navigation test in patients who are at risk of dementia.

The test involves use of a VR headset to take a navigation test while walking within a simulated environment.

Since successful completion of the task requires intact the entorhinal cortex functioning, patients with early Alzheimer’s disease are believed to be disproportionately affected on the test.

In 45 patients with mild cognitive impairment (MCI), the team obtained cerebrospinal fluid (CSF) samples and analysed for biomarkers of underlying Alzheimer’s. Of the total participants, 12 tested positive.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The study also involved 41 age-matched healthy controls for comparison. All MCI patients showed worse performance on the navigation task than the healthy controls.

In addition, MCI patients with positive CSF markers were observed to perform worse than those with negative markers.

“A VR test of navigation may be better at identifying early Alzheimer’s disease than tests we use at present in clinic and in research studies.”

The researchers also found that the VR navigation task was better at distinguishing low and high risk MCI patients than currently-used gold standard tests to diagnose early Alzheimer’s.

University of Cambridge clinical neurosciences department scientist Dr Dennis Chan said: “These results suggest a VR test of navigation may be better at identifying early Alzheimer’s disease than tests we use at present in clinic and in research studies.”

Findings from the study have been published in the Brain journal.

The researchers believe that VR could also help clinical trials of drugs intended to slow down, or halt Alzheimer’s progression.

In addition, Dr Chan formed alliances to develop apps to detect the disease and monitor its progression.